Most of the heritable risk of glioma is presently unaccounted for by mutations in known genes. In addition to rare inactivating germline mutations inTo comprehensively evaluate the impact of variation inThe strongest validated association signal was shown by the imputed single-nucleotide polymorphism (SNP) rs78378222 (Our data provided strong validation of rs78378222 as a risk factor for glioma but do not support the tenet that the polymorphism being a clinically useful prognostic marker. Acquired